We have the pleasure to offer you the 3rd Part of our 2021 Collection dedicated to Smart Pharma Consulting publications regarding Medical Affairs & Marketing, following the 1st part dedicated to Pharma Market Insights and the 2nd part dedicated to Strategy & Market Access.
News
Successfully navigating the Euro-5 orphan drug markets requires a deep understanding of country-specific market access frameworks, HTA...
Developing a strategy for rare diseases in France requires a clear understanding of the care ecosystem, key...
The French Voluntary Trade Organization (VTO) market is consolidating, making VTOs increasingly important partners for pharma companies...